Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05948878 · ClinicalTrials.gov registry record · NA
An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement
A NA study of Catheter Related Complication and Dislodged Catheter, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05948878: Completed NA study of Catheter Related Complication and Dislodged Catheter, sponsored by Boston Children's Hospital.
NCT05948878 is a NA study of Catheter Related Complication and Dislodged Catheter that has completed, run by Boston Children's Hospital. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05948878, a NA study of Catheter Related Complication and Dislodged Catheter, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single-blinded, randomized study to assess the ability of taping methods used to secure intravenous (IV) catheters to resist the IV from being pulled away from the skin. Participants will have IV catheters taped on top of the skin (without insertion into the skin) using three taping methods, BCH Emergency Department (BCH ED), Chevron, and our novel method. Six measurements will be obtained per subject (3 random taping methods measuring their resistance to force in two directions, retrograde direction or towards the wrist and 90-degree angle to the arm).
Primary Outcome
We will examine the maximum force the taping methods can withstand as measured by the force gauge in the retrograde direction, distally from the insertion site.
Conditions Studied
Interventions
- DEVICE Novel Taping Method
- DEVICE BCH Emergency Department Taping Method
- DEVICE Chevron Taping Method
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-28 |
| Est. Completion | 2023-11-09 |
| Phase | NA |
What the finished NCT05948878 record still lists
NCT05948878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Catheter Related Complication appearing as the primary indexed condition, and to 3 interventions - of which Novel Taping Method is the first listed.
NCT05948878 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05948878 about?
NCT05948878 is a clinical study titled "An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement". This is a prospective, single-blinded, randomized study to assess the ability of taping methods used to secure intravenous (IV) catheters to resist the IV from being pulled away from the skin. Participants will have IV catheters taped on top of the skin (without insertion into the skin) using three ...
What is the current status of trial NCT05948878?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-28. Estimated completion is 2023-11-09.
What conditions does trial NCT05948878 study?
This clinical trial studies the following conditions: Catheter Related Complication, Dislodged Catheter.
What interventions are being tested in trial NCT05948878?
The interventions under investigation include: Novel Taping Method (DEVICE), BCH Emergency Department Taping Method (DEVICE), Chevron Taping Method (DEVICE).
Who is sponsoring clinical trial NCT05948878?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05948878 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter Related Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05948878's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI